STRATA Skin Sciences Moves to Accelerate Medicare and Private Payer Coverage from Expanded CPT Code Expansion, Tripling Addressable Market to 30M+ Patients
Peer-reviewed publications continue to validate Excimer Laser efficacy in vitiligo and treatment
How could this development affect analyst sentiment and target price for STRATA's stock?
What are the potential regulatory or compliance considerations related to the expanded CPT code and coverage?
How might the new coverage affect STRATA's partnership or licensing agreements with insurers and healthcare providers?
22 days ago